524403 Sigma-AldrichPravastatin, Sodium Salt - CAS 81131-70-6 - Calbiochem
A water-soluble, competitive 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor that potently blocks in vivo cholesterol synthesis (Ki = ~1 nM).
More>> A water-soluble, competitive 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor that potently blocks in vivo cholesterol synthesis (Ki = ~1 nM). Less<<Sinonimi: (βR,δR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-β,δ,6-trihydroxy-2-methyl-8[(2S)-2-methyl-1-oxobutoxyl]-1-naphthaleneheptanoic Acid Na, 3β-Hydroxycompactin, Na
Prodotti consigliati
Panoramica
Replacement Information |
---|
Tabella delle specifiche principali
CAS # | Empirical Formula |
---|---|
81131-70-6 | C₂₃H₃₅O₇.Na |
Products
Numero di catalogo | Confezionamento | Qtà/conf | |
---|---|---|---|
524403-25MG | Plastic Bag(s) | 25 mg |
Product Information | |
---|---|
CAS number | 81131-70-6 |
ATP Competitive | N |
Form | White crystalline solid |
Hill Formula | C₂₃H₃₅O₇.Na |
Chemical formula | C₂₃H₃₅O₇.Na |
Hygroscopic | Hygroscopic |
Reversible | N |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Physicochemical Information | |
---|---|
Cell permeable | N |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS | |
---|---|
RTECS | QJ7185000 |
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Numero di catalogo | GTIN |
524403-25MG | 04055977270983 |
Documentation
Pravastatin, Sodium Salt - CAS 81131-70-6 - Calbiochem MSDS
Titolo |
---|
Pravastatin, Sodium Salt - CAS 81131-70-6 - Calbiochem Certificati d'Analisi
Titolo | Numero di lotto |
---|---|
524403 |
Riferimenti bibliografici
Panoramica delle referenze |
---|
Kwak, B., et al. 2000. Natl. Med. 6, 1399. Hamelin, B.A., and Turgeon, J., 1998. Trends Pharmacol. Sci. 19, 26. Narisawa, T., et al. 1996. Jpn. J. Cancer Res. 87, 798. Cohen, L.H., et al. 1993. Biochem. Pharmacol. 45, 2203. Koga, T., et al. 1990. Biochim. Biophys. Acta. 1045, 115. Yoshino, G., et al. 1986. Diabetes Res. Clin. Pract. 2, 179 |